Cost-effectiveness of therapy in nonatrial fibrillation.
Wiesel
J
J
D000925:Anticoagulants / Q000191:economics* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000628:therapy*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D004554:Electric Countershock; D006801:Humans; D012008:Recurrence; D012307:Risk Factors
D000925:Anticoagulants